Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. Am J Surg Pathol. 1997; 21:988–96., , , .
Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation. Arch Dermatol. 2000; 136:717–21., , .
Analysis of risk factors for acute cutaneous graft-versus-host disease after allogeneic stem cell transplantation. Br J Dermatol. 2003; 148:1129–34., , , et al.
Cutaneous graft-versus-host disease. Hautarzt. 2003; 54:465–80; quiz 481–2.
Graft-versus-host disease. N Engl J Med. 1991; 324:667–74., .
Bone-marrow transplantation. N Engl J Med. 1975; 292:895–902., , , et al.
Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GvHD. Bone Marrow Transplant. 1998; 21:29–32., , .
Cytokines in GvH and GvL. Bone Marrow Transplant. 1998; 22:S3–S6., , , .
GVHD: overview on pathophysiology, incidence, clinical and biological features. Bone Marrow Transplant. 1998; 21:S45–S49., .
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med. 1996; 334:281–5., , , et al.
Hematopoietic cell transplantation. 2nd ed. Malden (MA): Blackwell Science Inc.; 1999. pp. 515–36.. Graft-versus-host disease. In: , , , editors.
Hyperacute graft-versus-host disease in patients not given immunosuppression after allogeneic bone marrow transplantation. Blood. 1986; 67:1172–5., , , et al.
Graft-versus-host disease. Hautarzt. 1992; 43:669–77.
Toxic epidermal necrolysis possibly linked to hyperacute graft-versus-host disease. J Dermatol. 1997; 24:635–41., , , et al.
Clinical and diagnostic pathology of graft-versus-host disease. Berlin: Springer; 2002.
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974; 18:295–304., , , et al.
IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997; 97:855–64., , , et al.
Atypical skin graft-vs-host disease following bone marrow transplantation in an infant. Pediatr Transplant. 2007; 11:214–16., , , et al.
Acquired ichthyosis as a manifestation of acute cutaneous graft-versus-host disease. Pediatr Dermatol. 2007; 24:49–52., , , .
Epidermodysplasia verruciformis in the setting of graft-versus-host disease. J Am Acad Dermatol. 2007; 57:S78–S80., , , et al.
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Biol Blood Marrow Transplant. 2004; 10:178–85., , , et al.
Prognostic relevance of ‘early-onset’ graft-versus-host disease following non-myeloablative haematopoietic cell transplantation. Br J Haematol. 2005; 129:381–91., , , et al.
Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. Arch Dermatol. 2006; 142:175–82., , , .
Acute graft-versus-host disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management. Liver Transpl. 2007; 13:157–61., , , et al.
Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease. Am J Dermatopathol. 2007; 29:1–6., , , et al.
Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report. Leuk Res. 2007; 31:1603–4., , , et al.